• Protocols

• NCI10495

  OPEN TO ACCRUAL

  PH1 Study of DS-8201a in Combination with Neratinib in Solid Tumors with HER2 Alterations
  
  

• UW24148

  OPEN TO ACCRUAL

  A Ph 2 Study of BAY 2927088 in Pts w/ Solid Tumors w/ HER2-Activating Mutations